News
Wegovy (semaglutide) could offer a new option to treat severe liver disease based on new clinical trial evidence. The GLP-1 ...
8h
NewsNation on MSNOzempic, Wegovy could reverse severe liver disease, study suggestsDrugs made to treat diabetes and weight loss could stop or even reverse a severe liver disease, according to a new study. The ...
A new study reveals that semaglutide, a common diabetes medication, may effectively treat fatty liver disease, offering hope ...
Semaglutide, the blockbuster drug better known by brand names like Ozempic and Wegovy, has now shown significant promise in ...
Chief Medical Officer at Central DuPage Hospital Dr. Tom Moran joins Bob Sirott to talk about the risks of sitting for too ...
This time next year, you may be swapping your GLP-1 injections for easier and as-effective oral weight-loss medication. It's ...
Semaglutide, a GLP-1 receptor agonist sold under brand names Wegovy and Ozempic, is approved for weight loss and blood sugar ...
Too Much Chicken? New Research Finds Link to Increased Risk of Early DeathA recent study published in the journal Nutrients ...
How much do you truly know about the meaning of BMI? Body Mass Index, or BMI, is a number that reflects the relationship ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results